SCHEMBL29503754

SCHEMBL29503754

COc1ccc(Nc2cc(F)cc(F)c2)nc1C(=O)NC1CCc2ccc(C(F)(F)F)cc21

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 2/20 0.44
▸ PDE4B Q07343 2/20 0.44
▸ PDE4C Q08493 2/20 0.44
▸ PDE4D Q08499 2/20 0.44
▸ PDE10A Q9Y233 4/20 0.42
▸ ADORA2A P29274 1/20 0.39
▸ TAS1R3 Q7RTX0 1/20 0.39
▸ TAS1R1 Q7RTX1 1/20 0.39
▸ HCRTR1 O43613 3/20 0.39
▸ HCRTR2 O43614 2/20 0.39
▸ WDR5 P61964 3/20 0.37
▸ TRPV1 Q8NER1 2/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ TTR P02766 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CCR2 P41597 1/20 0.36
▸ DDB1 Q16531 1/20 0.36
▸ CRBN Q96SW2 1/20 0.36
▸ PDE2A O00408 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22716255 1.00 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL29503767 0.93 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL22716444 0.93 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL22730143 0.87 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL32663023 0.87 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL22727708 0.86 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL29503749 0.86 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL29503848 0.81 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL22716380 0.81 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL32663017 0.81 PDE2A (0.42) PDE4APDE4BPDE4CPDE4DPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12458021-B2 Microbiocidal derivatives SYNGENTA CROP PROTECTION AG (CH) 2025-11-04 — — US disclosed
CN-113874353-B Microbiocidal derivatives 先正达农作物保护股份公司 2024-06-14 — — CN disclosed
US-20220272976-A1 MICROBIOCIDAL DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2022-09-01 — — US disclosed
EP-3976586-A1 MICROBIOCIDAL DERIVATIVES Syngenta Crop Protection AG (CH) 2022-04-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220272976-A1 MICROBIOCIDAL DERIVATIVES MPO, MSR1, PRF1 PDE4A 990/4885PDE4B 867/4885PDE4C 1076/4885
US-12458021-B2 Microbiocidal derivatives MPO, MSR1, PRF1 PDE4A 990/4885PDE4B 867/4885PDE4C 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback